Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fortress Biotech

1.69
-0.0300-1.74%
Post-market: 1.750.0600+3.55%19:50 EDT
Volume:162.21K
Turnover:277.84K
Market Cap:49.91M
PE:-0.63
High:1.78
Open:1.75
Low:1.65
Close:1.72
Loading ...
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 05, 2023

Major Issues Report

8-K - Current report
Apr 19, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Apr 13, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 30, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 13, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 13, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 06, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 19, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Major Issues Report

8-K - Current report
Oct 21, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans